Sponsor

Women and Infants Hospital of Rhode Island

Clinical research sponsor

Published trials30
Recruiting shown4
Roles2
SourceClinicalTrials.gov

Clinical trials

30 shown
Bringing Medicines for HIV Prevention to a Family Planning ClinicNCT06930508 · lead sponsor · 2026-05-28
RECRUITING
Cardiovascular Protection After Preeclampsia With EnalaprilNCT07222852 · lead sponsor · 2026-01-01
RECRUITING
Rhode Island - Statewide Postpartum Hypertension Remote SurveillanceNCT06842875 · lead sponsor · 2025-04-15
RECRUITING
Low-Sodium Diet for Postpartum Blood Pressure ControlNCT07752056 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
Accuracy of Interstitial Continuous Glucose Sensors in NeonatesNCT07133906 · lead sponsor · 2025-09-01
NOT_YET_RECRUITING
Feasibility & Acceptability of App-based Cognitive Behavioral Therapy for Postpartum Depression PreventionNCT06365645 · lead sponsor · 2024-06-07
COMPLETED
Pilot Randomized Control Trial to Assess the Impact of Video Education on Postpartum Care Knowledge and Attendance Among Pregnant Individuals With DiabetesNCT07009106 · lead sponsor · 2023-08-01
COMPLETED
App-based Remote Blood Pressure MonitoringNCT05595629 · lead sponsor · 2022-11-07
COMPLETED
Timing of Ambulation and Infant Birth Weight in Gestational DiabetesNCT06157684 · lead sponsor · 2022-10-01
UNKNOWN
Adherence to Universal Aspirin Compared to Screening Indicated Aspirin for Prevention of PreeclampsiaNCT04797949 · lead sponsor · 2021-03-03
WITHDRAWN
A Pragmatic Approach to Lowering the Risk of Diabetes Mellitus After A Diagnosis of Gestational Diabetes MellitusNCT04615351 · lead sponsor · 2020-11-15
UNKNOWN
Comparison of Insulin Alone to Insulin With Metformin to Treat Gestational Diabetes MellitusNCT03651531 · lead sponsor · 2018-01-03
TERMINATED
Intrapartum Glucose Management Among Women With Gestational Diabetes MellitusNCT02596932 · lead sponsor · 2016-02-01
COMPLETED
PROPHYLACTIC ANTIBIOTICS PRIOR TO CESAREAN SECTION IN OBESE WOMENNCT01810354 · lead sponsor · 2013-04-01
COMPLETED
Partner-Specific HIV Risk Reduction Intervention for Drug-Using AdolescentsNCT00831883 · lead sponsor · 2009-02-01
COMPLETED
Pilot Study Comparing Hypnotherapy and Gabapentin for Hot Flashes.NCT00711529 · lead sponsor · 2008-07-01
COMPLETED
Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer.NCT00287482 · lead sponsor · 2005-10-01
TERMINATED
Passive Descent in Obese Nulliparous GravidaeNCT02080429 · lead sponsor
UNKNOWN
Intensive Glycemic Targets in Overweight and Obese Women With Gestational DiabetesNCT05124808 · collaborator · 2022-03-01
RECRUITING
IPT for Major Depression Following Perinatal Loss: Healing After Loss (HeAL)NCT04629599 · collaborator · 2021-08-01
COMPLETED
Glycemic Observation and Metabolic Outcomes in Mothers and OffspringNCT04860336 · collaborator · 2021-04-01
COMPLETED
BrUOG 351: PRE-OPERATIVE APBI USING NIBBNCT03437915 · collaborator · 2019-03-01
WITHDRAWN
Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer.NCT02789657 · collaborator · 2016-11-21
COMPLETED
Predictors of De-novo Development of Obstructive Sleep Apnea in PregnancyNCT02917876 · collaborator · 2016-11-01
ACTIVE_NOT_RECRUITING
Positive Airway Pressure, Sleep Apnea, and the Placenta (PAP-SAP)NCT02412696 · collaborator · 2015-06-01
ACTIVE_NOT_RECRUITING
Chronic Hypertension and Pregnancy (CHAP) ProjectNCT02299414 · collaborator · 2015-06-01
COMPLETED
The Health Check-Up for Expectant MomsNCT02120716 · collaborator · 2014-02-01
COMPLETED
Frequency of Blood Glucose Monitoring in Patients With Gestational DiabetesNCT01818557 · collaborator · 2013-05-01
COMPLETED
Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for RelapseNCT00462865 · collaborator · 2007-11-01
TERMINATED
Genetic Counseling for Menopausal Therapy Decision-Making for Women at Increased Risk for Breast CancerNCT00349011 · collaborator · 2002-08-01
COMPLETED

Sponsor roles

lead sponsor18
collaborator12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.